In contrast to TNF, which induces apoptosis both in cancer and healthy cells and thereby its administration in cancer patients causes unacceptable systemic toxicity, TRAIL selectively affects tumor cell survival without harming healthy cells [76]. The gene discussed is TNF; the disease is cancer.